+987.9%
MRNA vs SPXL
+29.9%
+958.0%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SPXL | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +4.8% | +8.3% | +9.2% |
| 7D | +20.6% | -2.5% | +23.1% | +23.0% |
| 30D | +27.1% | -4.3% | +31.5% | +32.2% |
| 3M | +353.4% | -4.2% | +357.6% | +374.1% |
| 6M | +446.3% | +15.0% | +431.2% | +406.1% |
| YTD | +776.2% | +28.4% | +747.7% | +644.8% |
| 1Y | +987.9% | +30.3% | +957.6% | +811.2% |
| All | +987.9% | +29.9% | +958.0% | +811.2% |
Cumulative growth
Daily Returns
Daily percentage return beside SPXL.
Daily Out/Under-Performance
Portfolio return minus SPXL return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SPXL return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SPXL wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling